Lanza Robert
Insider CIK 1317093 · ACTC Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 76,666 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 35,334 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 12,858 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 150,000 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 17,834 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 53,500 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 40,000 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | U Tender | 2016-02-10 | 2016-02-11 | 231,509 | $8.50 | $1.97M | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | S Sale | 2015-11-10 | 2015-11-10 | 10,000 | $8.36 | $83.6K | 206,509 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | S Sale | 2015-11-10 | 2015-11-10 | 10,000 | $8.36 | $83.6K | 196,509 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | S Sale | 2015-11-10 | 2015-11-10 | 15,000 | $8.25 | $123.8K | 216,509 | SEC↗ |
| ACTCD ADVANCED CELL TECHNOLOGY, | A Award deriv | 2014-09-12 | 2014-09-16 | 112,000 | — | $0 | 124,858 | SEC↗ |
| ACTCD ADVANCED CELL TECHNOLOGY, | A Award deriv | 2014-09-12 | 2014-09-18 | 112,000 | — | $0 | 112,000 | SEC↗ |
| ACTCD ADVANCED CELL TECHNOLOGY, | A Award | 2014-09-12 | 2014-09-16 | 56,000 | — | $0 | 231,509 | SEC↗ |
| ACTCD ADVANCED CELL TECHNOLOGY, | S Sale | 2014-09-10 | 2014-09-11 | 5,000 | $12.50 | $62.5K | 179,439 | SEC↗ |
| ACTCD ADVANCED CELL TECHNOLOGY, | S Sale | 2014-09-10 | 2014-09-11 | 3,930 | $12.57 | $49.4K | 175,509 | SEC↗ |
| ACTCD ADVANCED CELL TECHNOLOGY, | S Sale | 2014-09-08 | 2014-09-09 | 5,000 | $10.00 | $50.0K | 194,439 | SEC↗ |
| ACTCD ADVANCED CELL TECHNOLOGY, | S Sale | 2014-09-08 | 2014-09-09 | 10,000 | $10.07 | $100.7K | 184,439 | SEC↗ |
| ACTCD ADVANCED CELL TECHNOLOGY, | S Sale | 2014-09-03 | 2014-09-04 | 10,000 | $9.00 | $90.0K | 199,439 | SEC↗ |
| ACTCD ADVANCED CELL TECHNOLOGY, | S Sale | 2014-09-02 | 2014-09-04 | 5,000 | $9.01 | $45.0K | 209,439 | SEC↗ |
| ACTCD ADVANCED CELL TECHNOLOGY, | S Sale | 2014-09-02 | 2014-09-04 | 10,000 | $8.12 | $81.2K | 214,439 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2014-07-07 | 2014-07-07 | 745,000 | $0.08 | $59.6K | 22,443,822 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2014-07-03 | 2014-07-07 | 755,000 | $0.08 | $60.4K | 23,188,822 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award deriv | 2013-11-08 | 2013-11-12 | 1,285,714 | — | $0 | 1,285,714 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2013-11-08 | 2013-11-12 | 1,285,714 | — | $0 | 23,943,822 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-12-14 | 2013-02-05 | 100,000 | $0.06 | $6.0K | 22,662,085 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-12-14 | 2013-02-05 | 43,000 | $0.06 | $2.6K | 22,619,085 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-12-14 | 2013-02-05 | 20,000 | $0.06 | $1.2K | 23,937,575 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-12-14 | 2013-02-05 | 150,000 | $0.06 | $9.0K | 22,762,085 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-12-14 | 2013-02-05 | 545,490 | $0.06 | $32.7K | 22,912,085 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-12-14 | 2013-02-05 | 40,000 | $0.06 | $2.4K | 23,457,575 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-12-14 | 2013-02-05 | 440,000 | $0.06 | $26.4K | 23,497,575 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-12-14 | 2012-12-18 | 40,000 | $0.06 | $2.4K | 27,314,717 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-12-14 | 2012-12-18 | 100,000 | $0.06 | $6.0K | 26,519,227 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-12-14 | 2012-12-18 | 150,000 | $0.06 | $9.0K | 26,619,227 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-12-14 | 2012-12-18 | 545,490 | $0.06 | $32.7K | 26,769,227 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-12-14 | 2012-12-18 | 43,000 | $0.06 | $2.6K | 26,476,227 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-12-14 | 2012-12-18 | 440,000 | $0.06 | $26.4K | 27,354,717 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-12-14 | 2012-12-18 | 20,000 | $0.06 | $1.2K | 27,794,717 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2012-09-28 | 2012-12-18 | 1,285,714 | — | $0 | 27,814,717 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-07-31 | 2012-08-01 | 500,000 | $0.08 | $40.0K | 26,529,003 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-07-30 | 2012-08-01 | 151,500 | $0.08 | $12.1K | 27,765,796 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-07-30 | 2012-08-01 | 611,707 | $0.08 | $48.9K | 27,917,296 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-07-30 | 2012-08-01 | 546,793 | $0.08 | $43.7K | 27,219,003 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-07-30 | 2012-08-01 | 190,000 | $0.08 | $15.2K | 27,029,003 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2012-06-29 | 2012-07-26 | 1,285,714 | — | $0 | 28,529,003 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award | 2012-03-30 | 2012-07-26 | 1,285,714 | — | $0 | 27,243,289 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-01-24 | 2012-01-25 | 6,658,300 | $0.19 | $1.27M | 25,957,575 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | S Sale | 2012-01-23 | 2012-01-25 | 1,000,000 | $0.18 | $180.0K | 32,615,875 | SEC↗ |